1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004. 27:1047–1053.
3. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KM, Nair JD. Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001. 44:1094–1101.
4. Shera AS, Rafique G, Khwaja IA, Baqai S, Khan IA, King H. Pakistan National Diabetes Survey prevalence of glucose intolerance and associated factors in North West at Frontier Province (NWFP) of Pakistan. J Pak Med Assoc. 1999. 49:206–211.
5. Dong Y, Gao W, Nan H, Yu H, Li F, Duan W, Wang Y, Sun B, Qian R, Tuomilehto J, Qiao Q. Prevalence of type 2 diabetes in urban and rural Chinese populations in Qingdao, China. Diabet Med. 2005. 22:1427–1433.
6. Laskar SI. Urbanization in Bangladesh: some contemporary observations. Bangladesh Dev Stud. 1996. 24:207–216.
7. Bangladesh Bureau of Statistics. Statistical pocketbook of Bangladesh 2004. 2006. Dhaka: Bangladesh Bureau of Statistics.
8. Sayeed MA, Ali L, Hussain MZ, Rumi MA, Banu A, Azad Khan AK. Effect of socioeconomic risk factors on the difference in prevalence of diabetes between rural and urban populations in Bangladesh. Diabetes Care. 1997. 20:551–555.
9. Sayeed MA, Mahtab H, Akter Khanam P, Abdul Latif Z, Keramat Ali SM, Banu A, Ahren B, Azad Khan AK. Diabetes and impaired fasting glycemia in a rural population of Bangladesh. Diabetes Care. 2003. 26:1034–1039.
10. Hussain A, Rahim MA, Azad Khan AK, Ali SM, Vaaler S. Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh. Diabet Med. 2005. 22:931–936.
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997. 20:1183–1197.
12. Kanematsu N, Shibata KI. Investigation of DNA reactivity of endodontic agents by rec-assay. Gifu Shika Gakkai Zasshi. 1990. 17:592–597.
13. World Health Organization Regional Office for the Western Pacific. International Association for the Study of Obesity. International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. 2000. Sydney: Health Communications Australia.
14. Singha AC. Statistical pocketbook of Bangladesh 2000. 2002. Dhaka: Bangladesh Bureau of Statistics.
15. Ramachandran A, Snehalatha C, Baskar AD, Mary S, Kumar CK, Selvam S, Catherine S, Vijay V. Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India. Diabetologia. 2004. 47:860–865.
16. Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S, Bastar I, Tutuncu Y, Sargin M, Dinccag N, Karsidag K, Kalaca S, Ozcan C, King H. Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care. 2002. 25:1551–1556.
17. Grandinetti A, Chang HK, Mau MK, Curb JD, Kinney EK, Sagum R, Arakaki RF. Prevalence of glucose intolerance among native Hawaiians in two rural communities. Native Hawaiian Health Research (NHHR) Project. Diabetes Care. 1998. 21:549–554.
18. Rahim MA, Hussain A, Azad Khan AK, Sayeed MA, Keramat Ali SM, Vaaler S. Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study. Diabetes Res Clin Pract. 2007. 77:300–305.
19. Mohan V, Deepa M, Deepa R, Shanthirani CS, Farooq S, Ganesan A, Datta M. Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India: the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia. 2006. 49:1175–1178.
20. Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care. 2008. 31:893–898.
21. Soderberg S, Zimmet P, Tuomilehto J, de Courten M, Dowse GK, Chitson P, Gareeboo H, Alberti KG, Shaw JE. Increasing prevalence of type 2 diabetes mellitus in all ethnic groups in Mauritius. Diabet Med. 2005. 22:61–68.
22. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998. 21:518–524.
23. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002. 19:708–723.
24. Ramachandran A, Snehalatha C, Dharmaraj D, Viswanathan M. Prevalence of glucose intolerance in Asian Indians. Urban-rural difference and significance of upper body adiposity. Diabetes Care. 1992. 15:1348–1355.
25. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007. 49:69–75.
26. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000. 355:675–687.
27. Ikeda N, Gakidou E, Hasegawa T, Murray CJ. Understanding the decline of mean systolic blood pressure in Japan: an analysis of pooled data from the National Nutrition Survey, 1986-2002. Bull World Health Organ. 2008. 86:978–988.
28. Pourmoghaddas M, Khosravi A, Kelishadi R, Sarrafzadegan N, Shirani S, Ansari R, Sabet B. Trends in blood pressure level, prevalence and control of hypertension in Isfahan, Iran. Iran Heart J. 2004. 5:33–38.
29. Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A. Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. J Hypertens. 2000. 18:521–529.
30. Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A. Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens. 1997. 15:591–600.
31. Determinants of qualified hypertension diagnosis in surveillance sites of Bangladesh: findings from a cross-sectional study. Health Sci Bull. 2011. 9:15–18.
32. Mahmood SS, Iqbal M, Hanifi SM, Wahed T, Bhuiya A. Are 'Village Doctors' in Bangladesh a curse or a blessing? BMC Int Health Hum Rights. 2010. 10:18.
33. Cockcroft A, Andersson N, Milne D, Hossain MZ, Karim E. What did the public think of health services reform in Bangladesh? Three national community-based surveys 1999-2003. Health Res Policy Syst. 2007. 5:1.